0001971857-23-000276.txt : 20230615 0001971857-23-000276.hdr.sgml : 20230615 20230615101951 ACCESSION NUMBER: 0001971857-23-000276 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 231016228 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SANDERS MACHELLE CENTRAL INDEX KEY: 0001718020 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O NOVAN, INC. STREET 2: 4105 HOPSON ROAD CITY: MORRISVILLE STATE: NC ZIP: 27560 144 1 primary_doc.xml 144 0001718020 XXXXXXXX LIVE 0000882796 BIOCRYST PHARMACEUTICALS INC 000-23186 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302 SANDERS MACHELLE Officer Common Merrill Lynch

1152 15th St NW Suite 6000 Washington DC 20005

4000 31779.00 188934787 06/15/2023 NASDAQ Common 06/07/2023 Stock Plan Activity Issuer N 4000 06/07/2023 n/a Y 06/15/2023 Andrea Machelle Sanders